445 related articles for article (PubMed ID: 35954407)
1. Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy.
Hersh AM; Gaitsch H; Alomari S; Lubelski D; Tyler BM
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954407
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells.
Park MG; Seo S; Ham SW; Choi SH; Kim H
Oncol Lett; 2020 Aug; 20(2):1153-1162. PubMed ID: 32724355
[TBL] [Abstract][Full Text] [Related]
3. Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.
Tang X; Zuo C; Fang P; Liu G; Qiu Y; Huang Y; Tang R
Front Oncol; 2021; 11():701291. PubMed ID: 34307170
[TBL] [Abstract][Full Text] [Related]
4. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
6. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
Jin J; Grigore F; Chen CC; Li M
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
[TBL] [Abstract][Full Text] [Related]
7. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
8. The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies.
Ryskalin L; Gaglione A; Limanaqi F; Biagioni F; Familiari P; Frati A; Esposito V; Fornai F
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387280
[TBL] [Abstract][Full Text] [Related]
9. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
10. Emerging targets for glioblastoma stem cell therapy.
Safa AR; Saadatzadeh MR; Cohen-Gadol AA; Pollok KE; Bijangi-Vishehsaraei K
J Biomed Res; 2016 Jan; 30(1):19-31. PubMed ID: 26616589
[TBL] [Abstract][Full Text] [Related]
11. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
12. Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity.
Uribe D; Niechi I; Rackov G; Erices JI; San Martín R; Quezada C
Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205179
[TBL] [Abstract][Full Text] [Related]
13. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.
Visioli A; Trivieri N; Mencarelli G; Giani F; Copetti M; Palumbo O; Pracella R; Cariglia MG; Barile C; Mischitelli L; Soriano AA; Palumbo P; Legnani F; DiMeco F; Gorgoglione L; Pesole G; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2023 Sep; 42(1):244. PubMed ID: 37735434
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
[TBL] [Abstract][Full Text] [Related]
15. ISL1 Promotes Human Glioblastoma-Derived Stem Cells' Self-Renewal by Activation of Sonic Hedgehog/GLI1 Function.
Liu Y; Luan Y; Ma K; Zhang Z; Liu Y; Chen X
Stem Cells Dev; 2022 May; 31(9-10):258-268. PubMed ID: 35403434
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma cancer stem cell biology: Potential theranostic targets.
Sharifzad F; Ghavami S; Verdi J; Mardpour S; Mollapour Sisakht M; Azizi Z; Taghikhani A; Łos MJ; Fakharian E; Ebrahimi M; Hamidieh AA
Drug Resist Updat; 2019 Jan; 42():35-45. PubMed ID: 30877905
[TBL] [Abstract][Full Text] [Related]
17. NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells.
García-Gómez P; Golán I; S Dadras M; Mezheyeuski A; Bellomo C; Tzavlaki K; Morén A; Carreras-Puigvert J; Caja L
Mol Oncol; 2022 May; 16(9):1891-1912. PubMed ID: 35203105
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the STAT3 Signaling Pathway.
Yuk N; Jung HJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
[TBL] [Abstract][Full Text] [Related]
19. The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma.
Shi T; Zhu J; Zhang X; Mao X
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174078
[TBL] [Abstract][Full Text] [Related]
20. New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells.
Kawamura Y; Takouda J; Yoshimoto K; Nakashima K
Cell Biol Toxicol; 2018 Dec; 34(6):425-440. PubMed ID: 29383547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]